D'Orazio & Associates, Inc.

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 1646821 VIENNA, VA

Position in AUPH

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$232,387

New position

Shares Held

13,694

first reported quarter

Ownership

0.010%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#39

of 83 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

D'Orazio & Associates, Inc. holds $853,427 across 4 Biotechnology names. AUPH ranks #2 (27.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PBYI	Puma Biotechnology, Inc.	48,680	$394,794
2	AUPH	Aurinia Pharmaceuticals Inc. This page	13,694	$232,387
3	VRTX	Vertex Pharmaceuticals Inc / Ma	414	$205,646
4	NGEN	Nervgen Pharma Corp.	10,000	$20,600

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$232,387	13,694	—	Shares	Sole	2026-07-28
No filing history on record for this holder in this stock.